DEF 14A: Valhi, Inc. Announces Details for 2025 Annual Stockholders Meeting

Sentiment:

Proxy Statement


Valhi, Inc. sets date for its 2025 annual meeting of stockholders to elect directors and approve executive compensation.

Summary

  • Valhi, Inc. will hold its 2025 annual meeting of stockholders on May 22, 2025, in Dallas, Texas.
  • Stockholders will vote to elect seven director nominees and approve, on a nonbinding advisory basis, the company's named executive officer compensation.
  • The record date for determining stockholders eligible to vote is March 25, 2025.
  • Dixie Rice, which owns approximately 91.4% of Valhi's outstanding shares, intends to vote in favor of the director nominees and the executive compensation proposal.
  • The proxy statement and annual report are available online, and paper copies can be requested.
  • The board of directors recommends voting for the election of each director nominee and for the approval of the executive compensation proposal.

Sentiment

Score: 7

Explanation: The document is largely factual and procedural, outlining the details of the upcoming annual meeting and related corporate governance matters. The sentiment is neutral to slightly positive due to the expected approval of proposals and the presence of independent directors.

Positives

  • Dixie Rice's significant ownership stake (91.4%) ensures the likely passage of the board's recommendations.
  • The board of directors has a majority of independent directors.
  • The company provides multiple avenues for stockholders to vote, including online, by phone, and by mail.
  • The company has a clawback policy in place for the recovery of erroneously awarded compensation.

Negatives

  • Valhi is a controlled company, which means it is not required to have independent compensation, nominations, or corporate governance committees.
  • The company's executive officers are employed by Contran, which may raise concerns about potential conflicts of interest.
  • The company engages in numerous related party transactions, which could raise concerns about fairness and transparency.

Risks

  • Potential conflicts of interest arising from related party transactions and interlocking directorships.
  • Dependence on Contran for executive services and potential impact of Contran's financial health on Valhi.
  • Risk associated with the combined risk management program, where large losses incurred by one insured could leave other participating companies without adequate coverage.
  • Joint and several liability for the aggregate federal income tax liability of the Contran Tax Group.

Future Outlook

The company expects certain relationships and transactions with related parties, such as intercorporate services agreements, risk management programs, tax sharing agreements, and related party loans, to continue in 2025.

Management Comments

  • The board of directors believes that the full board of directors best represents the interests of all of our stockholders and that it is appropriate for all matters that would otherwise be considered by a nominations, corporate governance or risk oversight committee to be considered and acted upon by the full board of directors.
  • We believe the cost of the services received under our ISA with Contran, after considering the quality of the services received, is fair to us and is no less favorable to us than we could otherwise obtain from an unrelated third party for comparable services, based solely on our collective business judgment and experience without performing any independent market research.

Industry Context

The document provides insight into the corporate governance practices of a controlled company, which is relevant in the context of NYSE listing standards. It also highlights the use of intercorporate service agreements, which are common among companies with related ownership structures.

Comparison to Industry Standards

  • The company's director compensation structure, including retainers and meeting fees, is generally in line with industry standards for companies of similar size and complexity.
  • The use of a clawback policy is consistent with regulatory requirements and best practices for corporate governance.
  • The company's related party transaction policy is designed to ensure that such transactions are conducted on an arm's-length basis and are subject to independent review and approval.
  • The company's risk management program, which involves participation in a combined risk management program with related entities, is a common practice among companies with similar ownership structures.

Related Party Transactions

  • Valhi engages in numerous related party transactions with Contran and its affiliates, including intercorporate services agreements, risk management programs, tax sharing agreements, and related party loans.
  • These transactions are subject to review and approval by the audit committee or the independent directors of the board.
  • The company has a related party transaction policy in place to ensure that such transactions are conducted on an arm's-length basis and are in the best interests of the company.

Stakeholder Impact

  • Stockholders will have the opportunity to vote on the election of directors and the approval of executive compensation.
  • The company's corporate governance practices and related party transactions may impact investor confidence.
  • Employees may be affected by the intercorporate services agreements and the allocation of resources among related entities.
  • The company's risk management program and tax sharing agreement may have implications for its financial stability and tax liabilities.

Next Steps

  • Stockholders should review the proxy materials and vote on the proposals.
  • The company will hold its annual meeting on May 22, 2025.
  • The board of directors will continue to oversee the company's operations and corporate governance practices.

Key Dates

DateDescription
March 3, 2022Effective date of the amended and restated Valhi, Inc. Policy Regarding Related Party Transactions (RPT Policy).
October 2023Used payroll register month to estimate median employee compensation for pay ratio disclosure.
November 2023Board of directors adopted a policy for the recovery of erroneously awarded compensation, or clawback policy.
February 2024Kronos Worldwide entered into an unsecured subordinated term promissory note with Contran (the Contran Term Loan).
June 2024Valhi revised its financial statements for the quarterly and annual periods beginning in 2018 through the period ended December 31, 2023, due to a change in its recognition of a deferred tax asset.
July 1, 2024Effective date of the increase in the annual retainer for directors from $40,000 to $50,000.
August 2024Interest rate on the Contran Term Loan was amended from 11.5% to 9.54%.
November 2024Management made a presentation to the audit committee regarding participation in the combined risk management program.
December 31, 2024Amendment to the unsecured revolving promissory note with Contran to extend the demand period to no earlier than December 31, 2026.
January 2025Gina A. Norris became an independent director of Sammons Financial Group.
March 6, 2025Date of the Compensation Committee Report and Audit Committee Report.
March 25, 2025Record date for the 2025 annual meeting of stockholders.
April 2, 2025Date of the notice of annual meeting of stockholders.
April 8, 2025Approximate date for distributing the notice of internet availability of proxy materials.
May 22, 2025Date of the 2025 annual meeting of stockholders.
May 22, 2026First anniversary of this year's annual meeting.
December 9, 2025Deadline for stockholders to submit proposals for inclusion in next year's proxy statement.
January 22, 2026Deadline for stockholders to provide notice of intent to solicit proxies in support of director nominees other than Valhi's nominees.
May 22, 2026Approximate date of the 2026 annual stockholders meeting.
May 22, 2029Approximate date of the next nonbinding stockholder advisory vote on the frequency of a Say-on-Pay proposal.
December 31, 2025Date no earlier than which the unsecured revolving promissory note with Contran is due.
December 31, 2026Date no earlier than which the unsecured revolving promissory note with Contran is due.
September 2029Date no earlier than which the Contran Term Loan matures.
March 2026Date beginning when the Contran Term Loan is prepayable at par.

Keywords

annual meeting, proxy statement, director election, executive compensation, related party transactions, corporate governance, Dixie Rice, Contran, independent directors, risk management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.